Back to search

Article

Development of a Gene Editing Platform to Enhance CAR-T Therapy Through Inducible IL-15 Expression at the PD-1 Locus

2025-07-23

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Adoptive cell therapy (ACT) with genetically engineered T cells expressing chimeric antigen receptors (CARs) has emerged as a promising treatment option for patients with refractory leukaemia or lymphoma. Despite its success in type B malignancies, CAR-T cell therapy still faces some challenges such as toxicity, functional suppression by the tumour microenviro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
58ae2389-4008-5e32-b827-36531ed1840a
DOI
10.21203/rs.3.rs-7012598/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of a Gene Editing Platform to Enhance CAR-T Therapy Through Inducible IL-15 Expression at the PD-1 LocusDOI 10.21203/rs.3.rs-7012598/v1
Select a neighboring publication to make it the new centre.